Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,480 across all filing types
Latest filing 2026-05-26 Transaction in Own Shar…
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification for sale of treasury shares
Transaction in Own Shares Classification · 10% confidence The document is a corporate announcement under EU Regulation 596/2014 disclosing the company’s sale of its own treasury shares (29,500 shares sold at EUR 1.85 each) and updated treasury share holdings. This constitutes a transaction in the company’s own shares, fitting the “Transaction in Own Shares” category (POS).
2026-05-26 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 96% confidence The document announces the sale of treasury shares by the company under EU market abuse regulation, detailing the number of shares sold and remaining treasury shares. This is a report of a transaction in the company’s own shares, matching the definition for Transaction in Own Shares (POS).
2026-05-22 English
Publication of invitation and materials for the Annual General Meeting of Shareholders of "Sopharma" AD, convened for 26 June 2026
Regulatory Filings
2026-05-21 Polish
Notification for sale of treasury shares
Transaction in Own Shares Classification · 92% confidence The document is a regulatory notification under EU MAR (Regulation (EU) No 596/2014) disclosing the sale of treasury shares (2,000 shares) by Sopharma and the updated total of treasury shares held. This is a direct report of a transaction in the company’s own shares (sale of treasury stock), fitting the definition of code POS (Transaction in Own Shares).
2026-05-21 English
Notification for sales revenues for April 2026
Regulatory Filings Classification · 90% confidence The document is a brief "Current report" under Art.100t of the Bulgarian Law on Public Offering of Securities, simply notifying monthly sales figures (April 2026 sales growth) without providing full financial statements or substantive interim report. It is a routine regulatory disclosure rather than a detailed earnings release or interim report. It falls under general regulatory filings.
2026-05-20 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a notification about the sale of treasury shares by the company Sopharma AD. It specifies the number of shares sold, the percentage of share capital, the transaction date, and the price. This is a report of the company buying back or selling its own shares, which fits the definition of a Transaction in Own Shares (POS). The document is short and focused solely on this transaction, with no financial statements or other report content.
2026-05-19 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.